New study shows advantages of ellipsys system in creating reliable dialysis access

July 21, 2020

San Juan Capistrano, Calif. - A new study shows significant benefits of the Ellipsys® Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require hemodialysis. It also offers a standardized process for using the minimally invasive technology that other physicians can follow to reproduce the results, which "will make it easier for more practitioners to adopt this patient-friendly approach to dialysis access," explained lead author Alexandros Mallios, MD, a vascular surgeon at Institut Mutualiste Montsouris of Paris, France.

Hemodialysis requires access to the patient's bloodstream, which is often created by establishing a permanent connection between an artery and a vein in the arm known as an arteriovenous fistula (AVF). Traditionally, fistulas are created during an open surgical procedure by suturing the artery and vein together. In contrast,
Published in the
, this marks the largest study of any pAVF technique to date. Of the 232 patients who had an Ellipsys pAVF created between May 2017 and July 2019, there were no adverse events and 96 percent still had fully functioning fistulas with strong blood flow after a year. That "patency rate" is higher than published rates for surgically created fistulas, which average about 60% after one year.

"Vascular access is quite literally the lifeline for dialysis patients," said Dr. Mallios. "The advantages of the percutaneous Ellipsys fistula are that it is a very safe, simple and reproducible way to create a fistula that will function for a long time with minimal interventions."

In addition, the study reported that patients were able to begin using their pAVF for dialysis an average of four weeks after creation, with six percent of fistulas becoming functional (or "mature") in as little as two weeks. Such rapid maturation can have a significant impact on patient safety, as it avoids the use of a central venous catheter (CVC) if they need to begin dialysis quickly. Compared to fistulas, CVCs are associated with significantly higher rates of complications, including infection and even death.

One of the most important aspects of the study, Dr. Mallios added, is that it offers a protocol for fistula creation, maturation and maintenance--which should make it easier for other physicians to adopt the relatively new procedure. For example, the study shows the benefit of adding a new step to the procedure--performing balloon angioplasty immediately after a fistula is created. That improves blood flow and speeds maturation, and could improve patency rates without increasing the need for additional maintenance procedures.

"Dr. Mallios' results are very exciting, particularly with such a large patient population, as it adds to the growing body of evidence that this approach offers a safe and effective way to quickly create a functional percutaneous fistula," said Mark Ritchart, President and CEO of Avenu Medical. "He also uses his valuable experience as a guide to enable more widespread use of percutaneous fistulas, which may improve patient safety by reducing reliance on riskier vascular access options."

In April, JVS published a

In addition, recently published

Cleared by the FDA in 2018 for patients with end-stage kidney disease, Ellipsys is the first significant innovation in AVF creation in over 50 years. It transforms a complex surgery into a minimally invasive procedure that can be performed in a hospital outpatient setting or ambulatory surgery center. Since 2015, more than 1,800 patients worldwide have had the Ellipsys procedure.
-end-
About Avenu Medical

Avenu Medical, Inc. was founded in 2010 to pursue unmet clinical needs in the ESRD and vascular access markets. The company's Ellipsys Vascular Access System is an innovative, ultrasound-guided, single catheter endoAVF system used to percutaneously create an arteriovenous fistula for hemodialysis access. Learn more at
http://www.avenumedical.com.

Dowling & Dennis PR

Related Arteriovenous Fistula Articles from Brightsurf:

Minimally invasive Ellipsys system creates fused, permanent vascular access for dialysis
A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection (anastomosis) that is created with the minimally invasive Ellipsys® Vascular Access System.

Mathematical modelling to prevent fistulas
It is better to invest in measures that make it easier for women to visit a doctor during pregnancy than measures to repair birth injuries.

Ellipsys system offers greater patient eligibility and reduced time to dialysis
Two devices for creating minimally invasive dialysis access--the Ellipsys® Vascular Access System and the WavelinQ™ 4F System--demonstrated high rates of technical success and low rates of complications, according to a new study published in the Journal of Vascular and Interventional Radiology.

Minimally invasive ellipsys system allows kidney patients to begin dialysis sooner
The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study led by interventional radiologist Jeffrey Hull, M.D., of Richmond Vascular Center.

Yale-led surgical innovation promises better dialysis outcomes
A new technique developed by a Yale-led research team improves blood flow in surgically made blood vessels used in dialysis, enables them to last longer, and results in fewer complications than the standard technique.

New study identifies better treatment option for common complication of dialysis
Use of drug-coated balloon angioplasty to treat blocked blood vessels used for hemodialysis offers hope for millions of patients globally

A Reverse Approach to Vessel Surgery May Boost Clinical Outcomes in Dialysis
A new approach to a surgical procedure required for dialysis offers better long-term viability and a lower chance of complications compared with conventional techniques, according to work involving rats and 274 patients.

New study shows advantages of ellipsys system in creating reliable dialysis access
A new study shows significant benefits of the Ellipsys® Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require hemodialysis.

Without intervention, a 70% reduction in strokes or death in patients with brain AVMs
For people with a brain arteriovenous malformation (AVM), a congenital vascular system defect, fate has a name: stroke.

Serious complication of Crohn's disease may be preventable in young people
For children and young adults with Crohn's disease, steroid-sparing therapies may help reduce the risk of developing a severe and common complication of the inflammatory bowel condition, a new study suggests.

Read More: Arteriovenous Fistula News and Arteriovenous Fistula Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.